Intravitreal Lower- Dose (20 mu g) Melphalan for Persistent or Recurrent Retinoblastoma Vitreous Seeds


Tuncer S. , Balci O., Tanyildiz B., Kebudi R. , Shields C. L.

OPHTHALMIC SURGERY LASERS & IMAGING RETINA, cilt.46, ss.942-948, 2015 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 46 Konu: 9
  • Basım Tarihi: 2015
  • Doi Numarası: 10.3928/23258160-20151008-07
  • Dergi Adı: OPHTHALMIC SURGERY LASERS & IMAGING RETINA
  • Sayfa Sayıları: ss.942-948

Özet

BACKGROUND AND OBJECTIVE: The major cause of failure in the management of retinoblastoma is the persistence/recurrence of vitreous seeds (VS). This study reports the efficacy and complications of standard lower-dose (20 mu g) intravitreal melphalan for VS.